Largest pharmaceutical companies by cash on hand
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Johnson & Johnson leads the 61 pharmaceutical companies ranked by cash on hand, at DKK 134.2B, ahead of Merck & Co (DKK 99.2B) and Novartis (DKK 77.9B). Figures as of 18 Nov 2026, 22:17 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Johnson & JohnsonDKK 134.2B
- Median
- DKK 3.9B
- Combined market value
- DKK 34.45T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Cash on hand ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | DKK 134.2B | DKK 4.47T | DKK 1,856.84 | 2.15% down | 38% up | ||
| 2 | Merck & CoMRK · Health Care | DKK 99.2B | DKK 2.31T | DKK 938.16 | 3.90% down | 51% up | ||
| 3 | NovartisNVS · Health Care | DKK 77.9B | DKK 2T | DKK 1,056.84 | 2.46% down | 25% up | ||
| 4 | Bristol-Myers SquibbBMY · Health Care | DKK 69.5B | DKK 829B | DKK 405.55 | 2.92% down | 34% up | ||
| 5 | Abbott LaboratoriesABT · Health Care | DKK 58B | DKK 1.23T | DKK 711.41 | 0.22% down | 17% down | ||
| 6 | SanofiSNY · Health Care | DKK 57.8B | DKK 770.4B | DKK 320.84 | 0.86% down | 4% down | ||
| 7 | Eli LillyLLY · Health Care | DKK 49.5B | DKK 8.39T | DKK 9,415.28 | 2.32% down | 35% up | ||
| 8 | AstraZenecaAZN · Health Care | DKK 38.9B | DKK 1.89T | DKK 1,217.19 | 1.93% down | 2% up | ||
| 9 | AbbVieABBV · Health Care | DKK 35.6B | DKK 3.44T | DKK 1,947.47 | 2.33% down | 26% up | ||
| 10 | Vertex PharmaceuticalsVRTX · Health Care | DKK 34.6B | DKK 926.1B | DKK 3,652.74 | 0.42% up | 27% up | ||
| 11 | BeOne MedicinesONC · Health Care | DKK 31B | DKK 313.9B | DKK 2,748.15 | 2.34% down | 17% up | ||
| 12 | GSKGSK · Health Care | DKK 30.7B | DKK 663.1B | DKK 330.79 | 1.34% down | 6% up | ||
| 13 | Novo NordiskNVO · Health Care | DKK 26.7B | DKK 1.18T | DKK 268.48 | 3.12% down | 17% down | ||
| 14 | Takeda PharmaceuticalTAK · Health Care | DKK 25.4B | DKK 462.7B | DKK 144.83 | 1.71% down | 54% up | ||
| 15 | Teva Pharmaceutical IndustriesTEVA · Health Care | DKK 24.2B | DKK 335.5B | DKK 287.55 | 0.92% down | 74% up | ||
| 16 | Regeneron PharmaceuticalsREGN · Health Care | DKK 21.2B | DKK 666B | DKK 6,438.21 | 1.28% down | 36% up | ||
| 17 | ZoetisZTS · Health Care | DKK 15.7B | DKK 236.7B | DKK 582.65 | 2.50% up | 29% down | ||
| 18 | GenmabGMAB · Health Care | DKK 11.7B | DKK 214B | DKK 347.06 | 1.91% down | 70% up | ||
| 19 | Alnylam PharmaceuticalsALNY · Health Care | DKK 11.3B | DKK 136.3B | DKK 1,017.28 | 4.54% down | 66% down | ||
| 20 | United TherapeuticsUTHR · Health Care | DKK 10.6B | DKK 167.4B | DKK 3,931.17 | 1.16% down | 23% up | ||
| 21 | Roivant SciencesROIV · Health Care | DKK 9.7B | DKK 191.1B | DKK 263.72 | 0.05% up | 90% up | ||
| 22 | Jazz PharmaceuticalsJAZZ · Health Care | DKK 9.5B | DKK 108.3B | DKK 1,687.09 | 2.93% up | 37% up | ||
| 23 | ViatrisVTRS · Health Care | DKK 9B | DKK 158.3B | DKK 138.09 | 0.83% down | 96% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | DKK 8.9B | DKK 81B | DKK 418.28 | 4.99% up | 11% up | ||
| 25 | PfizerPFE · Health Care | DKK 7.8B | DKK 1.09T | DKK 191.06 | 1.44% down | 14% up | ||
| 26 | PTC TherapeuticsPTCT · Health Care | DKK 6.7B | DKK 34.3B | DKK 410.11 | 0.22% down | 20% down | ||
| 27 | GrifolsGRFS · Health Care | DKK 6.2B | DKK 39.3B | DKK 57.67 | 1.85% down | 1% up | ||
| 28 | Legend BiotechLEGN · Health Care | DKK 6.1B | DKK 21.5B | DKK 110.65 | 0.87% up | 42% down | ||
| 29 | Ascendis PharmaASND · Health Care | DKK 4.7B | DKK 120.7B | DKK 1,840.70 | 0.32% down | 28% up | ||
| 30 | Royalty PharmaRPRX · Health Care | DKK 4.2B | DKK 268.9B | DKK 467.58 | 0.01% down | 78% up | ||
| 31 | ABIVAXABVX · Health Care | DKK 3.9B | DKK 50B | DKK 570.81 | 2.11% up | 27% down | ||
| 32 | BridgeBio PharmaBBIO · Health Care | DKK 3.9B | DKK 103.5B | DKK 531.18 | 1.58% up | 17% up | ||
| 33 | Elanco Animal HealthELAN · Health Care | DKK 3.7B | DKK 90.9B | DKK 181.80 | 3.29% up | 20% up | ||
| 34 | InsmedINSM · Health Care | DKK 3.5B | DKK 179B | DKK 815.73 | 1.69% down | 40% down | ||
| 35 | AlkermesALKS · Health Care | DKK 2.6B | DKK 53.6B | DKK 319.01 | 3.08% up | 58% up | ||
| 36 | Ionis PharmaceuticalsIONS · Health Care | DKK 2.5B | DKK 31.1B | DKK 186.50 | 1.59% up | 64% down | ||
| 37 | Praxis Precision MedicinesPRAX · Health Care | DKK 2.4B | DKK 58.1B | DKK 2,078.07 | 0.04% up | 61% up | ||
| 38 | Belite BioBLTE · Health Care | DKK 2.4B | DKK 43.2B | DKK 1,063.79 | 0.94% down | 31% up | ||
| 39 | Axsome TherapeuticsAXSM · Health Care | DKK 2.2B | DKK 48B | DKK 912.42 | 1.43% down | 7% down | ||
| 40 | Cogent BiosciencesCOGT · Health Care | DKK 2.1B | DKK 32.9B | DKK 189.36 | 0.14% down | 20% down | ||
| 41 | Mirum PharmaceuticalsMIRM · Health Care | DKK 2B | DKK 41.1B | DKK 629.77 | 0.59% up | 31% up | ||
| 42 | Amneal PharmaceuticalsAMRX · Health Care | DKK 1.9B | DKK 51.9B | DKK 148.98 | 3.60% up | 83% up | ||
| 43 | Definium TherapeuticsDFTX · Health Care | DKK 1.8B | DKK 27.1B | DKK 198.28 | 0.88% down | 169% up | ||
| 44 | Arrowhead PharmaceuticalsARWR · Health Care | DKK 1.5B | DKK 41.5B | DKK 293.54 | 0.28% up | 10% up | ||
| 45 | Summit TherapeuticsSMMT · Health Care | DKK 1.5B | DKK 57.2B | DKK 71.50 | 1.59% down | 36% down | ||
| 46 | Madrigal PharmaceuticalsMDGL · Health Care | DKK 1.4B | DKK 63B | DKK 2,710.57 | 5.67% down | 24% down | ||
| 47 | Ligand PharmaceuticalsLGND · Health Care | DKK 1.2B | DKK 40.7B | DKK 2,033.95 | 1.67% up | 43% up | ||
| 48 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | DKK 1.1B | DKK 50.9B | DKK 647.20 | 0.06% down | 126% up | ||
| 49 | Dr. Reddy's LaboratoriesRDY · Health Care | DKK 1.1B | DKK 85B | DKK 102.00 | 1.28% up | 5% up | ||
| 50 | Protagonist TherapeuticsPTGX · Health Care | DKK 874.2M | DKK 56.5B | DKK 865.85 | 2.00% up | 46% up | ||
| 51 | CytokineticsCYTK · Health Care | DKK 834.2M | DKK 48.7B | DKK 349.44 | 0.64% down | 20% down | ||
| 52 | Corcept TherapeuticsCORT · Health Care | DKK 820.5M | DKK 50.5B | DKK 461.59 | 3.25% down | 8% down | ||
| 53 | Travere TherapeuticsTVTX · Health Care | DKK 633.5M | DKK 32.8B | DKK 342.09 | 1.68% down | 44% up | ||
| 54 | Spyre TherapeuticsSYRE · Health Care | DKK 583.7M | DKK 65.6B | DKK 690.85 | 8.15% up | 286% up | ||
| 55 | TG TherapeuticsTGTX · Health Care | DKK 538.9M | DKK 68B | DKK 450.22 | 5.44% up | 107% up | ||
| 56 | ErascaERAS · Health Care | DKK 502.5M | DKK 32.9B | DKK 93.69 | 0.94% down | 403% up | ||
| 57 | Edgewise TherapeuticsEWTX · Health Care | DKK 416.4M | DKK 30.8B | DKK 281.69 | 1.59% down | 88% up | ||
| 58 | Rhythm PharmaceuticalsRYTM · Health Care | DKK 369.7M | DKK 56.2B | DKK 810.56 | 2.08% up | 13% up | ||
| 59 | Dianthus TherapeuticsDNTH · Health Care | DKK 347.9M | DKK 32.2B | DKK 571.83 | 3.45% down | 113% up | ||
| 60 | Oruka TherapeuticsORKA · Health Care | DKK 319.6M | DKK 44.2B | DKK 651.90 | 0.60% down | 241% up | ||
| 61 | VeradermicsMANE · Health Care | DKK 148.2M | DKK 35.9B | DKK 850.18 | 0.62% down | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 6.8091 DKK).
Questions and answers
Which pharmaceutical companies rank first by cash on hand?
Johnson & Johnson (DKK 134.2B), Merck & Co (DKK 99.2B) and Novartis (DKK 77.9B) are the top three of the 61 pharmaceutical companies ranked by cash on hand as of 18 Nov 2026, 22:17 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by cash on hand.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by cash on hand have a combined market value of DKK 34.45T as of 18 Nov 2026, 22:17 UTC.
What does ranking by cash on hand measure?
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies by cash on hand”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=cash-on-hand
Underlying data: Yahoo Finance; SEC EDGAR.